A part of Watch Medier Director, Drug Safety Operations Clinical Supply Manager Medical Writer responsible for Clinical Disclosure Global Clinical Lead, Clinical Development, Migraine & Pain Senior Safety Manager Pharmacokineticist, PK/PD Modelling & Simulation You need to be a subscriber to read the rest of the article
Follow-Up and Monitoring After the initial diagnosis and treatment plan are in place, follow-up appointments and monitoring are essential
By blocking HAI-1, Dihexa allows endogenous HGF to remain active for longer periods and at higher effective concentrations
A study from Theratechnologies (the company behind Egrifta) analyzed 400 participants and found that among treatment responders, resolution of elevated triglycerides occurred in 17.5% compared to just 8% of non-responders (p=0.026)
MORE CONVENIENCE Simply heat and eat our meals in two minutesno shopping or cooking required
This protocol was applied to exacerbate metabolic impairment in the models of PCOS, commonly seen in this syndrome, and as a means to define adverse conditions where to test the therapeutic potential of the selected multi-agonists